Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

PETER SHALIT

Allopathic & Osteopathic Physicians Internal Medicine

NPI
1831181700
CMS profile
264345
Location
SEATTLE, WA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2025 · Entire year

$186,665.18

236 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2025 · entire year · sorted by reported total

By paying entity

PY2025 · entire year · sorted by reported total

Page 2 of 5; records 51–100 of 236 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

PETER SHALIT

NPI 1831181700 · CMS profile ID 264345

Allopathic & Osteopathic Physicians / Internal Medicine

SEATTLE, WA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 5; records 51–100 of 236 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1831181700?year=2025&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
PETER SHALIT, NPI 1831181700, CMS profile ID 264345. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 5; records 51–100 of 236 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1831181700?year=2025&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
APA 7
IndustryPayments. (2026). PETER SHALIT, NPI 1831181700, CMS profile ID 264345. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 5; records 51–100 of 236 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1831181700?year=2025&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
Bluebook
PETER SHALIT, NPI 1831181700, CMS profile ID 264345, IndustryPayments, General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 5; records 51–100 of 236 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e. https://industrypayments.org/provider/npi-1831181700?year=2025&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2025 · Physicians and non-physician practitioners · CMS publication 2026-06-30

236 matching records · $186,665.18 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 236 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 236.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Gilead Sciences, Inc. $2,450.0010/22/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1234356872 CMS
Gilead Sciences, Inc. $477.6110/22/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1234366095 CMS
Lilly USA, LLC $19.1710/22/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1186756475 CMS
ViiV Healthcare Company $37.0310/18/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1189520504 CMS
ViiV Healthcare Company $57.8510/18/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1189552142 CMS
ViiV Healthcare Company $75.2110/18/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1189602663 CMS
ViiV Healthcare Company $96.0410/18/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1189612826 CMS
ViiV Healthcare Company $30.0810/18/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1189628577 CMS
Gilead Sciences, Inc. $490.0010/17/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1234360371 CMS
ViiV Healthcare Company $20.2610/15/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1189519346 CMS
ViiV Healthcare Company $31.4110/14/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1189522874 CMS
ViiV Healthcare Company $298.7110/14/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1189566373 CMS
ViiV Healthcare Company $31.4110/14/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1189571205 CMS
ViiV Healthcare Company $189.7310/14/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1189582144 CMS
Gilead Sciences, Inc. $27.8510/09/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1234452514 CMS
ViiV Healthcare Company $475.2610/07/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1189547311 CMS
Novo Nordisk Inc $26.4210/01/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1189068141 CMS
Gilead Sciences, Inc. $4,170.0009/24/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1234354271 CMS
Gilead Sciences, Inc. $1,715.0009/24/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1234358029 CMS
Gilead Sciences, Inc. $614.4709/22/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1234365143 CMS
Gilead Sciences, Inc. $818.0609/17/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1234364273 CMS
Gilead Sciences, Inc. $14.2509/17/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1234576121 CMS
ViiV Healthcare Company $125.0009/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1189554526 CMS
Gilead Sciences, Inc. $72.1009/09/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1234409053 CMS
ViiV Healthcare Company $3,900.0009/08/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1189571127 CMS
ViiV Healthcare Company $31.4109/08/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1189584031 CMS
ViiV Healthcare Company $445.7709/08/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1189615840 CMS
ViiV Healthcare Company $27.6409/03/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1189528862 CMS
ViiV Healthcare Company $3,900.0009/02/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1189517808 CMS
EMD Serono, Inc. $7,315.0008/14/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1236887130 CMS
Gilead Sciences, Inc. $16.4408/13/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1234562321 CMS
ViiV Healthcare Company $2,600.0008/08/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1189601072 CMS
ViiV Healthcare Company $303.8908/06/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1189554646 CMS
ViiV Healthcare Company $834.8608/06/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1189567459 CMS
ViiV Healthcare Company $9,750.0008/06/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1189577612 CMS
ViiV Healthcare Company $105.0808/06/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1189590893 CMS
ViiV Healthcare Company $109.3307/31/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1189513698 CMS
ViiV Healthcare Company $992.8107/31/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1189567691 CMS
ViiV Healthcare Company $310.7307/31/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1189612848 CMS
Gilead Sciences, Inc. $702.0007/30/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1234364675 CMS
ViiV Healthcare Company $2.2807/30/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1189630703 CMS
Gilead Sciences, Inc. $2,450.0007/29/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1234356870 CMS
ViiV Healthcare Company $28.0007/29/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1189592300 CMS
EMD Serono, Inc. $1,202.7907/23/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1236873988 CMS
EMD Serono, Inc. $85.0107/23/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1236886868 CMS
EMD Serono, Inc. $119.9907/23/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1236889144 CMS
EMD Serono, Inc. $144.7307/23/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1236889748 CMS
ViiV Healthcare Company $10.8607/23/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1189520840 CMS
ViiV Healthcare Company $110.0707/23/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1189579974 CMS
Gilead Sciences, Inc. $124.9907/22/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1234384614 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $216,544.03 308
PY2020 $75,108.86 161
PY2021 $49,651.83 94
PY2022 $159,958.06 191
PY2023 $186,006.86 233
PY2024 $136,756.27 177
PY2025 $186,665.18 236

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Recipient $29,236.33 14
PY2025 Principal investigator $243,584.39 18
PY2024 Recipient $33,049.36 15
PY2024 Principal investigator $22,159.89 5
PY2023 Recipient $26,309.10 16
PY2023 Principal investigator $70,650.14 15
PY2022 Principal investigator $75,561.43 28
PY2021 Recipient $30,846.00 11
PY2021 Principal investigator $292,680.37 32
PY2020 Recipient $359,957.47 33
PY2020 Principal investigator $73,894.19 30
PY2019 Recipient $465,816.58 58
PY2019 Principal investigator $500.00 1

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

32 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Recipient Gilead Sciences, Inc. $2,667.00 12/16/2025 Covered Recipient Physician A Phase 3, Double-Blind, Multicenter, Randomized Study to Evaluate the Efficacy and Safety of Subcutaneous Twice Yearly Long-Acting Lenacapavir for HIV Pre-Exposure Prophylaxis in Cisgender Men, Transgender Women, Transgender Men, and Gender Non-binary People >= 16 Years of Age who Have Sex with Male Partners and are at Risk for HIV Infection No dispute reported 06/30/2026 1229215485
Principal investigator 1 ViiV Healthcare Company $17,799.51 11/18/2025 Non-covered Recipient Entity
PETER SHALIT MD AND ASSOCIATES
A PHASE 2B SINGLE ARM, REPEAT DOSE STUDY TO EVALUATE THE PHARMACOKINET No dispute reported 06/30/2026 1190319113
Principal investigator 1 ViiV Healthcare Company $27,815.83 10/31/2025 Non-covered Recipient Entity
PETER SHALIT MD AND ASSOCIATES
A PHASE 2B SINGLE ARM, REPEAT DOSE STUDY TO EVALUATE THE PHARMACOKINET No dispute reported 06/30/2026 1190319111
Recipient Gilead Sciences, Inc. $2,572.00 09/23/2025 Covered Recipient Physician A Phase 3, Double-Blind, Multicenter, Randomized Study to Evaluate the Efficacy and Safety of Subcutaneous Twice Yearly Long-Acting Lenacapavir for HIV Pre-Exposure Prophylaxis in Cisgender Men, Transgender Women, Transgender Men, and Gender Non-binary People >= 16 Years of Age who Have Sex with Male Partners and are at Risk for HIV Infection No dispute reported 06/30/2026 1229215475
Recipient Gilead Sciences, Inc. $1,369.00 09/16/2025 Covered Recipient Physician A Phase 3, Double-Blind, Multicenter, Randomized Study to Evaluate the Efficacy and Safety of Subcutaneous Twice Yearly Long-Acting Lenacapavir for HIV Pre-Exposure Prophylaxis in Cisgender Men, Transgender Women, Transgender Men, and Gender Non-binary People >= 16 Years of Age who Have Sex with Male Partners and are at Risk for HIV Infection No dispute reported 06/30/2026 1229215467
Principal investigator 1 ViiV Healthcare Company $19,816.50 09/15/2025 Non-covered Recipient Entity
PETER SHALIT MD AND ASSOCIATES
A PHASE 2B SINGLE ARM, REPEAT DOSE STUDY TO EVALUATE THE PHARMACOKINET No dispute reported 06/30/2026 1190317045
Recipient Gilead Sciences, Inc. $1,365.12 09/09/2025 Covered Recipient Physician A Phase 3, Double-Blind, Multicenter, Randomized Study to Evaluate the Efficacy and Safety of Subcutaneous Twice Yearly Long-Acting Lenacapavir for HIV Pre-Exposure Prophylaxis in Cisgender Men, Transgender Women, Transgender Men, and Gender Non-binary People >= 16 Years of Age who Have Sex with Male Partners and are at Risk for HIV Infection No dispute reported 06/30/2026 1229215457
Recipient Gilead Sciences, Inc. $2,930.00 08/19/2025 Covered Recipient Physician A Phase 3, Double-Blind, Multicenter, Randomized Study to Evaluate the Efficacy and Safety of Subcutaneous Twice Yearly Long-Acting Lenacapavir for HIV Pre-Exposure Prophylaxis in Cisgender Men, Transgender Women, Transgender Men, and Gender Non-binary People >= 16 Years of Age who Have Sex with Male Partners and are at Risk for HIV Infection No dispute reported 06/30/2026 1229215446
Principal investigator 1 ViiV Healthcare Company $18,680.48 08/15/2025 Non-covered Recipient Entity
PETER SHALIT MD AND ASSOCIATES
A PHASE 2B SINGLE ARM, REPEAT DOSE STUDY TO EVALUATE THE PHARMACOKINET No dispute reported 06/30/2026 1190319107
Recipient Gilead Sciences, Inc. $1,646.00 07/22/2025 Covered Recipient Physician A Phase 3, Double-Blind, Multicenter, Randomized Study to Evaluate the Efficacy and Safety of Subcutaneous Twice Yearly Long-Acting Lenacapavir for HIV Pre-Exposure Prophylaxis in Cisgender Men, Transgender Women, Transgender Men, and Gender Non-binary People >= 16 Years of Age who Have Sex with Male Partners and are at Risk for HIV Infection No dispute reported 06/30/2026 1229215436
Principal investigator 1 ViiV Healthcare Company $31,739.42 07/22/2025 Non-covered Recipient Entity
PETER SHALIT MD AND ASSOCIATES
A PHASE 2B SINGLE ARM, REPEAT DOSE STUDY TO EVALUATE THE PHARMACOKINET No dispute reported 06/30/2026 1190317049
Principal investigator 1 ViiV Healthcare Company $500.00 06/23/2025 Non-covered Recipient Entity
PETER SHALIT MD AND ASSOCIATES
A PHASE 2B SINGLE ARM, REPEAT DOSE STUDY TO EVALUATE THE PHARMACOKINET No dispute reported 06/30/2026 1190317047
Principal investigator 1 ViiV Healthcare Company $350.00 06/23/2025 Non-covered Recipient Entity
PETER SHALIT MD AND ASSOCIATES
A PHASE 2B SINGLE ARM, REPEAT DOSE STUDY TO EVALUATE THE PHARMACOKINET No dispute reported 06/30/2026 1190318945
Principal investigator 1 ViiV Healthcare Company $400.00 06/23/2025 Non-covered Recipient Entity
PETER SHALIT MD AND ASSOCIATES
A PHASE 2B SINGLE ARM, REPEAT DOSE STUDY TO EVALUATE THE PHARMACOKINET No dispute reported 06/30/2026 1190318949
Principal investigator 1 ViiV Healthcare Company $500.00 06/23/2025 Non-covered Recipient Entity
PETER SHALIT MD AND ASSOCIATES
A PHASE 2B SINGLE ARM, REPEAT DOSE STUDY TO EVALUATE THE PHARMACOKINET No dispute reported 06/30/2026 1190318951
Principal investigator 1 ViiV Healthcare Company $500.00 06/23/2025 Non-covered Recipient Entity
PETER SHALIT MD AND ASSOCIATES
A PHASE 2B SINGLE ARM, REPEAT DOSE STUDY TO EVALUATE THE PHARMACOKINET No dispute reported 06/30/2026 1190319101
Principal investigator 1 ViiV Healthcare Company $350.00 06/23/2025 Non-covered Recipient Entity
PETER SHALIT MD AND ASSOCIATES
A PHASE 2B SINGLE ARM, REPEAT DOSE STUDY TO EVALUATE THE PHARMACOKINET No dispute reported 06/30/2026 1190319103
Recipient Gilead Sciences, Inc. $2,697.00 06/17/2025 Covered Recipient Physician A Phase 3, Double-Blind, Multicenter, Randomized Study to Evaluate the Efficacy and Safety of Subcutaneous Twice Yearly Long-Acting Lenacapavir for HIV Pre-Exposure Prophylaxis in Cisgender Men, Transgender Women, Transgender Men, and Gender Non-binary People >= 16 Years of Age who Have Sex with Male Partners and are at Risk for HIV Infection No dispute reported 06/30/2026 1229215426
Principal investigator 1 ViiV Healthcare Company $11,290.86 06/12/2025 Non-covered Recipient Entity
PETER SHALIT MD AND ASSOCIATES
A PHASE 2B SINGLE ARM, REPEAT DOSE STUDY TO EVALUATE THE PHARMACOKINET No dispute reported 06/30/2026 1190317053
Principal investigator 1 ViiV Healthcare Company $59,079.19 05/26/2025 Non-covered Recipient Entity
PETER SHALIT MD AND ASSOCIATES
A PHASE 2B SINGLE ARM, REPEAT DOSE STUDY TO EVALUATE THE PHARMACOKINET No dispute reported 06/30/2026 1190319109
Recipient Gilead Sciences, Inc. $1,646.00 05/20/2025 Covered Recipient Physician A Phase 3, Double-Blind, Multicenter, Randomized Study to Evaluate the Efficacy and Safety of Subcutaneous Twice Yearly Long-Acting Lenacapavir for HIV Pre-Exposure Prophylaxis in Cisgender Men, Transgender Women, Transgender Men, and Gender Non-binary People >= 16 Years of Age who Have Sex with Male Partners and are at Risk for HIV Infection No dispute reported 06/30/2026 1229215419
Principal investigator 1 ViiV Healthcare Company $18,669.73 05/14/2025 Non-covered Recipient Entity
PETER SHALIT MD AND ASSOCIATES
A PHASE 2B SINGLE ARM, REPEAT DOSE STUDY TO EVALUATE THE PHARMACOKINET No dispute reported 06/30/2026 1190319105
Recipient Gilead Sciences, Inc. $1,319.66 05/01/2025 Covered Recipient Physician A Phase 3, Double-Blind, Multicenter, Randomized Study to Evaluate the Efficacy and Safety of Subcutaneous Twice Yearly Long-Acting Lenacapavir for HIV Pre-Exposure Prophylaxis in Cisgender Men, Transgender Women, Transgender Men, and Gender Non-binary People >= 16 Years of Age who Have Sex with Male Partners and are at Risk for HIV Infection No dispute reported 06/30/2026 1229215409
Principal investigator 1 ViiV Healthcare Company $20,249.37 04/28/2025 Non-covered Recipient Entity
PETER SHALIT MD AND ASSOCIATES
A PHASE 2B SINGLE ARM, REPEAT DOSE STUDY TO EVALUATE THE PHARMACOKINET No dispute reported 06/30/2026 1190319115
Recipient Gilead Sciences, Inc. $1,284.00 04/22/2025 Covered Recipient Physician A Phase 3, Double-Blind, Multicenter, Randomized Study to Evaluate the Efficacy and Safety of Subcutaneous Twice Yearly Long-Acting Lenacapavir for HIV Pre-Exposure Prophylaxis in Cisgender Men, Transgender Women, Transgender Men, and Gender Non-binary People >= 16 Years of Age who Have Sex with Male Partners and are at Risk for HIV Infection No dispute reported 06/30/2026 1229215400
Principal investigator 1 ViiV Healthcare Company $6,012.50 04/17/2025 Non-covered Recipient Entity
VAXCARE AT PETER SHALIT MD AND ASSOCIATES
A PHASE 4, RANDOMIZED, OPEN-LABEL, TWO-ARM STUDY EVALUATING IMPLEMENTA No dispute reported 06/30/2026 1190318947
Recipient Gilead Sciences, Inc. $1,498.00 03/18/2025 Covered Recipient Physician A Phase 3, Double-Blind, Multicenter, Randomized Study to Evaluate the Efficacy and Safety of Subcutaneous Twice Yearly Long-Acting Lenacapavir for HIV Pre-Exposure Prophylaxis in Cisgender Men, Transgender Women, Transgender Men, and Gender Non-binary People >= 16 Years of Age who Have Sex with Male Partners and are at Risk for HIV Infection No dispute reported 06/30/2026 1229215393
Recipient Gilead Sciences, Inc. $3,055.00 02/19/2025 Covered Recipient Physician A Phase 3, Double-Blind, Multicenter, Randomized Study to Evaluate the Efficacy and Safety of Subcutaneous Twice Yearly Long-Acting Lenacapavir for HIV Pre-Exposure Prophylaxis in Cisgender Men, Transgender Women, Transgender Men, and Gender Non-binary People >= 16 Years of Age who Have Sex with Male Partners and are at Risk for HIV Infection No dispute reported 06/30/2026 1229215384
Principal investigator 1 ViiV Healthcare Company $7,793.00 02/11/2025 Non-covered Recipient Entity
PETER SHALIT MD AND ASSOCIATES
A PHASE 2B SINGLE ARM, REPEAT DOSE STUDY TO EVALUATE THE PHARMACOKINET No dispute reported 06/30/2026 1190317051
Principal investigator 1 ViiV Healthcare Company $2,038.00 02/11/2025 Non-covered Recipient Entity
PETER SHALIT MD AND ASSOCIATES
A PHASE 2B SINGLE ARM, REPEAT DOSE STUDY TO EVALUATE THE PHARMACOKINET No dispute reported 06/30/2026 1190317055
Recipient Gilead Sciences, Inc. $4,295.00 01/22/2025 Covered Recipient Physician A Phase 3, Double-Blind, Multicenter, Randomized Study to Evaluate the Efficacy and Safety of Subcutaneous Twice Yearly Long-Acting Lenacapavir for HIV Pre-Exposure Prophylaxis in Cisgender Men, Transgender Women, Transgender Men, and Gender Non-binary People >= 16 Years of Age who Have Sex with Male Partners and are at Risk for HIV Infection No dispute reported 06/30/2026 1229215374
Recipient Gilead Sciences, Inc. $892.55 01/07/2025 Covered Recipient Physician A Phase 3, Double-Blind, Multicenter, Randomized Study to Evaluate the Efficacy and Safety of Subcutaneous Twice Yearly Long-Acting Lenacapavir for HIV Pre-Exposure Prophylaxis in Cisgender Men, Transgender Women, Transgender Men, and Gender Non-binary People >= 16 Years of Age who Have Sex with Male Partners and are at Risk for HIV Infection No dispute reported 06/30/2026 1229215362